ERCC1 and bone neoplasm: ERCC1 rs735482 is involved in the identification and removing platinum-induced intra-strand adducts in DNA, and is resistant to platinum-based chemotherapy in many cancers, including non-small cell lung cancer, ovarian cancer, bone tumor, and colorectal cancer.[13,28–31]